Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Habermann

Showing results (31-40 of 374) with videos related to

Pageof 38
Sort By:
World Neurosurgery|July 10, 2025
Low-Grade B-Cell Neurolymphomatosis: A Case Series and Diagnostic InsightKen Porche, Rebecca L King, Thomas M Habermann, et al.
Leukemia & Lymphoma|June 25, 2021
Relationship between uric acid and kidney function in adults at risk for tumor lysis syndromeHeather P May, Kristin C Mara, Erin F Barreto, et al.
Journal of Neurosurgery|June 5, 2007
Epstein-Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor. Case reportMikko Larsen, Thomas M Habermann, Allen T Bishop, et al.
JAMA|September 24, 2009
Association of resident fatigue and distress with perceived medical errorsColin P West, Angelina D Tan, Thomas M Habermann, et al.
Mayo Clinic Proceedings|May 15, 2003
Strategies for improving attendance at medical grand rounds at an academic medical centerPaul S Mueller, Scott C Litin, Monica L Sowden, et al.
Leukemia & Lymphoma|September 14, 2019
Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern eraKekoa Taparra, Heshan Liu, Mei-Yin Polley, et al.
Leukemia & Lymphoma|September 7, 2018
Cryptococcus neoformans infections in patients with lymphoproliferative neoplasmsMaria V Dioverti, Sameer A Parikh, Douglas R Osmon, et al.
Mayo Clinic Proceedings|March 15, 2006
Current status of medical grand rounds in departments of medicine at US medical schoolsPaul S Mueller, Colin M Segovis, Scott C Litin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphomaStephen M Ansell, Kay M Ristow, Thomas M Habermann, et al.
Journal of Neuro-Oncology|December 23, 2011
Secondary intramedullary spinal cord non-Hodgkin's lymphomaEoin P Flanagan, Brian Patrick O'Neill, Thomas M Habermann, et al.
Pageof 38

Showing results (31-40 of 374) with videos related to

Sort By:
Pageof 38
World Neurosurgery|July 10, 2025
Low-Grade B-Cell Neurolymphomatosis: A Case Series and Diagnostic InsightKen Porche, Rebecca L King, Thomas M Habermann, et al.
Leukemia & Lymphoma|June 25, 2021
Relationship between uric acid and kidney function in adults at risk for tumor lysis syndromeHeather P May, Kristin C Mara, Erin F Barreto, et al.
Journal of Neurosurgery|June 5, 2007
Epstein-Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor. Case reportMikko Larsen, Thomas M Habermann, Allen T Bishop, et al.
JAMA|September 24, 2009
Association of resident fatigue and distress with perceived medical errorsColin P West, Angelina D Tan, Thomas M Habermann, et al.
Mayo Clinic Proceedings|May 15, 2003
Strategies for improving attendance at medical grand rounds at an academic medical centerPaul S Mueller, Scott C Litin, Monica L Sowden, et al.
Leukemia & Lymphoma|September 14, 2019
Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern eraKekoa Taparra, Heshan Liu, Mei-Yin Polley, et al.
Leukemia & Lymphoma|September 7, 2018
Cryptococcus neoformans infections in patients with lymphoproliferative neoplasmsMaria V Dioverti, Sameer A Parikh, Douglas R Osmon, et al.
Mayo Clinic Proceedings|March 15, 2006
Current status of medical grand rounds in departments of medicine at US medical schoolsPaul S Mueller, Colin M Segovis, Scott C Litin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphomaStephen M Ansell, Kay M Ristow, Thomas M Habermann, et al.
Journal of Neuro-Oncology|December 23, 2011
Secondary intramedullary spinal cord non-Hodgkin's lymphomaEoin P Flanagan, Brian Patrick O'Neill, Thomas M Habermann, et al.
Pageof 38